- Home
- KMDA vs AWP Comparison
KMDA vs AWP Comparison
Compare KMDA & AWP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KMDA
- AWP
- Stock Information
- Founded
- KMDA 1990
- AWP 2007
- Country
- KMDA Israel
- AWP United States
- Employees
- KMDA N/A
- AWP N/A
- Industry
- KMDA Biotechnology: Pharmaceutical Preparations
- AWP Trusts Except Educational Religious and Charitable
- Sector
- KMDA Health Care
- AWP Finance
- Exchange
- KMDA Nasdaq
- AWP Nasdaq
- Market Cap
- KMDA 410.6M
- AWP 349.3M
- IPO Year
- KMDA N/A
- AWP N/A
- Fundamental
- Price
- KMDA $6.95
- AWP $4.01
- Analyst Decision
- KMDA Strong Buy
- AWP
- Analyst Count
- KMDA 2
- AWP 0
- Target Price
- KMDA $13.00
- AWP N/A
- AVG Volume (30 Days)
- KMDA 50.0K
- AWP 331.5K
- Earning Date
- KMDA 11-12-2025
- AWP 01-01-0001
- Dividend Yield
- KMDA 2.90%
- AWP 12.48%
- EPS Growth
- KMDA 27.97
- AWP N/A
- EPS
- KMDA 0.32
- AWP N/A
- Revenue
- KMDA $169,517,000.00
- AWP N/A
- Revenue This Year
- KMDA $14.49
- AWP N/A
- Revenue Next Year
- KMDA $10.12
- AWP N/A
- P/E Ratio
- KMDA $20.92
- AWP N/A
- Revenue Growth
- KMDA 9.67
- AWP N/A
- 52 Week Low
- KMDA $5.17
- AWP $3.06
- 52 Week High
- KMDA $9.16
- AWP $4.20
- Technical
- Relative Strength Index (RSI)
- KMDA 44.35
- AWP 53.57
- Support Level
- KMDA $6.84
- AWP $4.01
- Resistance Level
- KMDA $7.15
- AWP $4.07
- Average True Range (ATR)
- KMDA 0.19
- AWP 0.04
- MACD
- KMDA -0.00
- AWP -0.00
- Stochastic Oscillator
- KMDA 23.02
- AWP 50.00
About KMDA Kamada Ltd.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
About AWP abrdn Global Premier Properties Fund of Beneficial Interest
Aberdeen Global Premier Properties Fund is a diversified, closed-end management investment company. Its objective is to seek high current income and capital appreciation. It predominantly invests in equity and debt securities of domestic and foreign issuers which are principally engaged in the real estate industry, real estate financing or control real estate assets. Its portfolio of investments consists securities of Industrial REITs, Retail REITs, Data Center REITs, Health Care REITs and others.